Topoisomerase II alpha and II beta expression in childhood acute lymphoblastic leukaemia: relation to prognostic factors and clinical outcome
about
Loss of nuclear expression of the p33(ING1b) inhibitor of growth protein in childhood acute lymphoblastic leukaemiaRapid upregulation of telomerase activity in human leukemia HL-60 cells treated with clinical doses of the DNA-damaging drug etoposide.High levels of topoisomerase IIalpha protein expression in diffuse large B-cell lymphoma are associated with high proliferation, germinal center immunophenotype, and response to treatment.
P2860
Topoisomerase II alpha and II beta expression in childhood acute lymphoblastic leukaemia: relation to prognostic factors and clinical outcome
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Topoisomerase II alpha and II ...... c factors and clinical outcome
@ast
Topoisomerase II alpha and II ...... c factors and clinical outcome
@en
Topoisomerase II alpha and II ...... c factors and clinical outcome
@nl
type
label
Topoisomerase II alpha and II ...... c factors and clinical outcome
@ast
Topoisomerase II alpha and II ...... c factors and clinical outcome
@en
Topoisomerase II alpha and II ...... c factors and clinical outcome
@nl
prefLabel
Topoisomerase II alpha and II ...... c factors and clinical outcome
@ast
Topoisomerase II alpha and II ...... c factors and clinical outcome
@en
Topoisomerase II alpha and II ...... c factors and clinical outcome
@nl
P2093
P2860
P356
P1476
Topoisomerase II alpha and II ...... c factors and clinical outcome
@en
P2093
G G McIntosh
J J Anderson
P2860
P356
10.1136/JCP.54.1.31
P407
P577
2001-01-01T00:00:00Z